Conference AFPS 2023

Asian Federation for Pharmaceutical Sciences 2023
"Collaboration for Breakthroughs in Pharmaceutical Sciences"

November 8 - 10, 2023 | Melia Hanoi Hotel, Hanoi, Viet Nam

Lee, Jeewoo사진 Prof. Jeewoo Lee - Seoul National University Chul Soon Yong | Academic Editor | Journal of Biomedical Research &  Environmental Sciences Prof. Chul Soon Yong - Yeungnam University image01 Prof. Amit Misra - CSIR-Central Drug Research Institute Prof. Kim Chan Prof. Hak-Kim Chan - The University of Sydney Prof. George P. Patrinos -  University of Patras. Loop | Federico Marini Prof. Federico Marini - University of Rome “La Sapienza Pham_Viet.jpg Prof. Pham Hung Viet - VNU University of Science Chih-Kuang Yeh.jpg Prof. Chih-Kuang Yeh - National Tsing Hua University Makiya Nishikawa.jpg Prof. Makiya Nishikawa - Tokyo University of Science



Title and full name


Research interest


Tentative topic for presentation

Professor Jeewoo Lee

Laboratory of Medicinal Chemistry
Research Institute of Pharmaceutical Sciences
College of Pharmacy
Seoul National University
Seoul 08826, Republic of Korea
Phone: 880-7846/880-9172

1. TRPV1 ligands as neuropathic pain drugs
2. RAGE antagonists as Alzheimer drugs
3. β-Amyloid aggregation inhibitors as Alzheimer drugs
4. PKC ligands as anticancer agents

Lee, Jeewoo사진

Discovery of Highly Potent Glutaminyl Cyclase (QC) Inhibitors as Anti-Alzheimer's Agents

Chul Soon Yong

Laboratory of Pharmaceutics
College of Pharmacy
Yeungnam University
Republic of Korea

Pharmaceutics, technological pharmacology, pharmacology

Chul Soon Yong | Academic Editor | Journal of Biomedical Research &  Environmental Sciences

Nanoparticles for chemo-immunotherapy of cancer


George P. Patrinos

Head of the Laboratory of Pharmacogenomics and Individualized Medicine, Department of Pharmacy

 University of Patras.

Adjunct Professorships at Erasmus MC, Faculty of Medicine, Rotterdam (the Netherlands) and the United Arab Emirates University, College of Medicine, Department of Pathology, Al-Ain (UAE). Full Member and Greece’s National representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA, Amsterdam, the Netherlands) and Co-Chair of the Global Genomic Medicine Collaborative (G2MC)

Chief Editor of The Pharmacogenomics Journal – Nature


Implementation of Pharmacogenomics into clinical settings – Experience of the EU

Professor Amit Misra

Pharmaceutics and Pharmacokinetics Division
CSIR-Central Drug Research Institute
Lucknow 226031
Tel: 0522-2772450 EPABX-2360

Pharmaceutics, vaccine delivery


Comparing and Contrasting Dry Powder Inhalations for use in COVID-19 and Tuberculosis

Professor Hak-Kim Chan

Advanced Drug Delivery Group
Faculty of Medicine and Health
Sydney Pharmacy School
The University of Sydney
Sydney, New South Wales, Australia - S341, Pharmacy and Bank Building A15, The University of Sydney, NSW, 2006, Australia
Tel.: +61 2 9351 EXT 3054

Pharmacy, Respiratory Medicine

Professor Kim Chan

Inhaled phage delivery for respiratory infections caused by superbugs

Professsor Federico Marini

Department of Chemistry, University of Rome “La Sapienza



Loop | Federico Marini

Chemomerics-based spectroscopy in biomedical and pharmaceutical analysis

Professor Pham Hung Viet

VNU Key Laboratory of Analytical Technology for Environmental Quality and Food Safety Control (KLATEFOS), VNU University of Science


Analytical Chemistry


Professor Chih-Kuang Yeh

Chairman of Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University.

No. 101, Section 2, Kuang-Fu Road, Hsinchu, Taiwan 300044, R.O.C.

Tel: 03-572-5077

Ultrasound Image Processing, Biomedical Signal Processing, Biomedical Engineering


Biology, genes, cancer and tumor

theranostics using self-designed ultrasound imaging system and contrast agents

Professor Makiya Nishikawa

Laboratory of Biopharmaceutics

Faculty of Pharmaceutical Sciences

Tokyo University of Science

2641 Yamazaki, Noda, Chiba 278-8510, Japan

Phone/Fax: +81-4-7121-4450



Nucleic acid-based drug delivery systems and cell therapeutics


Structural optimization of oligonucleotide therapeutics for targeted or sustained delivery